Growth Metrics

Gilead Sciences (GILD) Total Debt Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5.97%
Dec 31, 2025 -4.51%
Sep 30, 2025 -3.16%
Jun 30, 2025 0.69%
Mar 31, 2025 0.70%
Dec 31, 2024 1.67%
Sep 30, 2024 -1.11%
Jun 30, 2024 -2.19%
Mar 31, 2024 -1.06%
Dec 31, 2023 -1.77%
Sep 30, 2023 -1.77%
Jun 30, 2023 -2.77%
Mar 31, 2023 -2.78%
Dec 31, 2022 -5.54%
Sep 30, 2022 -2.93%
Jun 30, 2022 -0.06%
Mar 31, 2022 -0.09%
Dec 31, 2021 0.26%
Sep 30, 2021 0.45%
Jun 30, 2021 6.40%
Mar 31, 2021 5.74%
Dec 31, 2020 7.32%
Sep 30, 2020 5.68%
Jun 30, 2020 14.45%
Mar 31, 2020 14.28%
Dec 31, 2019 14.67%
Sep 30, 2019 21.18%
Jun 30, 2019 22.37%
Mar 31, 2019 22.07%
Dec 31, 2018 32.72%
Sep 30, 2018 30.16%
Jun 30, 2018 31.69%
Mar 31, 2018 29.43%
Dec 31, 2017 32.46%
Sep 30, 2017 27.25%
Jun 30, 2017 23.65%
Mar 31, 2017 22.79%
Dec 31, 2016 28.20%
Sep 30, 2016 47.38%
Jun 30, 2016 41.66%
Mar 31, 2016 38.35%
Dec 31, 2015 44.63%
Sep 30, 2015 103.78%
Mar 31, 2015 344.96%
Dec 31, 2014 366.96%
Sep 30, 2014 114.84%
Jun 30, 2014 87.92%